远程缺血适应可能改善脑小血管病患者结局
这项前瞻性随机对照研究纳入30例脑小血管病相关轻度认知障碍患者,随机分为远程缺血适应组(n=14)和假适应组(n=16),治疗1年。结果显示远程缺血适应组白质高信号体积较基线显著减少,且视空间与执行能力、血脂及同型半胱氨酸等指标改善优于假适应组。提示远程缺血适应可能延缓认知下降并减少白质高信号。
要点
- 远程缺血适应组白质高信号体积较基线显著减少(9.10±7.42 vs 6.46±6.05 cm3,P=0.020)。
- 远程缺血适应组视空间与执行能力改善优于假适应组(0.639 vs 0.191,P=0.048)。
- 远程缺血适应组血脂和同型半胱氨酸下降幅度大于假适应组。
核心结论
- 远程缺血适应可能对脑小血管病患者有效,可延缓认知下降并减少白质高信号。
研究设计与样本
- 前瞻性随机对照研究,纳入30例脑小血管病相关轻度认知障碍患者,随机分为远程缺血适应组(n=14)和假适应组(n=16),干预1年。
主要发现
- 远程缺血适应组治疗后白质高信号体积较治疗前显著减少(9.10±7.42 vs 6.46±6.05 cm3,P=0.020),假适应组无显著差异(8.99±6.81 vs 8.07±6.56 cm3,P=0.085)。
- 远程缺血适应组白质高信号体积减少幅度大于假适应组(-2.632 vs -0.935 cm3,P=0.049)。
- 两组腔隙灶数量变化无显著差异(0 vs 0,P=0.694)。
- 1年时两组视空间与执行能力变化有显著差异(0.639 vs 0.191,P=0.048)。
- 远程缺血适应组血浆甘油三酯(-0.433 vs 0.236 mmol/L,P=0.005)、总胆固醇(-0.975 vs 0.134 mmol/L,P<0.001)、低密度脂蛋白(-0.645 vs -0.029 mmol/L,P=0.034)及同型半胱氨酸(-4.737 vs -1.679 µmol/L,P=0.044)变化均优于假适应组。
临床怎么用
- 在脑小血管病相关轻度认知障碍患者中,可考虑试用远程缺血适应作为辅助治疗,但需更多研究验证。
局限性
- 样本量较小(共30例),研究结果需在更大规模人群中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: We aimed to evaluate the efficacy of remote ischemic conditioning (RIC) in patients with cerebral small-vessel disease. METHODS: Thirty patients with cerebral small-vessel disease-related mild cognitive impairment were enrolled in this prospective, randomized controlled study for 1 year. Besides routine medical treatment, participants were randomized into the experimental group (n=14) undergoing 5 cycles consisting of ischemia followed by reperfusion for 5 minutes on both upper limbs twice daily for 1 year or the control group (n=16) who were treated with sham ischemia-reperfusion cycles. The primary outcome was the change of brain lesions, and secondary outcomes were changes of cognitive function, plasma biomarkers, and cerebral hemodynamic parameters both at baseline and at the end of 1-year follow-up. RESULTS: Compared with pretreatment, the post-treatment white matter hyperintensities volume in the RIC group was significantly reduced (9.10±7.42 versus 6.46±6.05 cm3; P=0.020), whereas no significant difference was observed in the sham-RIC group (8.99±6.81 versus 8.07±6.56 cm3; P=0.085). The reduction of white matter hyperintensities volume in the RIC group was more substantial than that in sham group (-2.632 versus -0.935 cm3; P=0.049). No significant difference was found in the change of the number of lacunes between 2 groups (0 versus 0; P=0.694). A significant treatment difference at 1 year on visuospatial and executive ability was found between the 2 groups (0.639 versus 0.191; P=0.048). RIC showed greater effects compared with sham-RIC on plasma triglyceride (-0.433 versus 0.236 mmol/L; P=0.005), total cholesterol (-0.975 versus 0.134 mmol/L; P<0.001), low-density lipoprotein (-0.645 versus -0.029 mmol/L; P=0.034), and homocysteine (-4.737 versus -1.679 µmol/L; P=0.044). Changes of the pulsation indices of middle cerebral arteries from the baseline to 1 year were different between the 2 groups (right: -0.075 versus 0.043; P=0.030; left: -0.085 versus 0.043; P=0.010). CONCLUSIONS: RIC seems to be potentially effective in patients with cerebral small-vessel disease in slowing cognition decline and reducing white matter hyperintensities. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT01658306.
引用
- Wang Y, Meng R, Song H, et al. Remote Ischemic Conditioning May Improve Outcomes of Patients With Cerebral Small-Vessel Disease. Stroke. 2017. PMID: 29042490. doi:10.1161/STROKEAHA.117.017691
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。